Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - calcium carbonate; cholecalciferol; magnesium oxide; sodium ascorbate; calcium ascorbate dihydrate -

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - calcium carbonate; calcium pantothenate; cholecalciferol; cyanocobalamin; manganese sulphate monohydrate; pyridoxine hydrochloride; thiamine hydrochloride; cupric sulfate anhydrous; zinc sulfate monohydrate; magnesium oxide heavy -

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - vitamin d3 (cholecalciferol 5mcg as dry vitamin d3 type 100cws); calcium carbonate -

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - calcium carbonate; vitamin d3 (cholecalciferol) -

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - calcium carbonate; vitamin k2; vitamin d3 (cholecalciferol) -

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - thiamine hydrochloride; calcium carbonate; calcium pantothenate; magnesium oxide; pyridoxine hydrochloride; cyanocobalamin; cholecalciferol -

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - calcium carbonate; cholecalciferol -

Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurobio sdn bhd - calcium carbonate; magnesium oxide; vitamin k2; cholecalciferol -

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 17751 - bone matrix implant, synthetic - beta-tricalcium phosphate provides a highly porous resorbable and osteoconductive scaffold that provides a framework for bone ingrowth, aids in preventing soft tissue infiltration and promotes stabilization of the blood clot. it is mixed with recombinant human platelet-derived growth factor bb (rhpdgf-bb), prior to implantation which stimulates the recruitment and proliferation of a variety of cell types, including bone cells and mesenchymal stem cells, while also promoting revascularization. augment bone graft is indicated for use as an alternative to autograft in hindfoot and ankle fusion procedures that require supplemental graft material, including tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 47967 - bone matrix implant, composite - a medical device/drug combination product which is intended to be used for physically filling bone defects by providing a biocompatible, osteoconductive scaffold for new bone formation and promoting cellular in-growth into the osseous defect. composed of a 0.5 g or 1 g matrix material comprised of 20% bovine type i collagen and 80% beta-tricalcium phosphate (100 ? 300 ?m mean particle diameter); and a 1.5 ml or 3 ml solution of 0.3 mg/ml rhpdgf-bb in a 20mm sodium acetate buffer. augment injectable bone graft is indicated for use as an alternative to autograft in hindfoot and ankle fusion procedures that require supplemental graft material, including tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions.